A Phase II Basket Study of the Oral TRK Inhibitor LOXO-101 in Subjects with NTRK Fusion-Positive Tumors

Sponsor
Loxo Oncology

Protocol Number
Loxo Oncology LOXO-TRK-15002

To Learn More Call
201-510-0910